We have previously shown that administration of 5 mg/kg/day continuous infusion in a bleomycin induced pulmonary fibrosis model in mice was both therapeutically efficacious and reduced Wnt signaling as judged by reduction of X-Gal staining in the lungs in the Bat-Gal transgenic reporter mice utilized in these studies [8]. This evidence concerns the gene GAL and pulmonary fibrosis.